Veterinary Pharmaceuticals Global Market Report 2021 by The Business Research Company is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact – both negative and positive – of COVID-19 on the veterinary pharmaceuticals industry gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. This includes revised market numbers according to the effects of the coronavirus and the expected veterinary pharmaceuticals market growth numbers 2021-2030.

View Complete Report:
https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

The Veterinary Pharmaceuticals Global Market Report 2020-30 by The Business Research Company provides an in-depth analysis of the global veterinary pharmaceuticals market and covers both the historic period, 2015 to 2020, and the forecast period, 2020 to 2030. The report evaluates the market and major economies across the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Veterinary Pharmaceuticals Global Market Report 2021 covers veterinary pharmaceuticals market drivers, veterinary pharmaceuticals market trends, veterinary pharmaceuticals market growth rate, veterinary pharmaceuticals market major players, player-adopted strategies in the market, and veterinary pharmaceuticals market size.

The global veterinary pharmaceuticals market is expected to decline from $14.8 billion in 2019 to $13.1 billion in 2020 at a compound annual growth rate (CAGR) of -11.6%. The decline is mainly due to the COVID-19 outbreak and the measures to contain it. COVID-19 pandemic is affecting industries across the globe including the animal sector. The restrictions on non-essential medical services coupled with slowed production of veterinary pharmaceuticals due to extended factory closures in various countries, shortage of APIs and other chemicals, and rise in prices of key ingredients are the key factors for this decline. The market is then expected to recover and grow at a CAGR of 7.5% from 2021 and reach $19.7 billion in 2023.

Request For The Sample Now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3407&type=smp

The report covers the veterinary pharmaceuticals market segments-
1) By Type: Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Others.
2) By End User: Veterinary Hospitals, Veterinary Clinics, Pharmacies and Drug Stores.
3) By Route of Administration: Oral, Others (Parental, Topical).
4) By Animal Type: Companion Animals, Livestock Animals.
5) By Vaccines: Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines.

About The Business Research Company:
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 20+ countries globally.

Get a quick glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Blog: http://blog.tbrc.info/